International Journal of STD & AIDS > Volume 8, Number 5 > Pp. 299-302

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, H Articles by Mcmillan, A Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Azithromycin and erythromycin resistant Neisseria gonorrhoea e following treatment with azithromycin

H Young, A Moyes and A Mcmillan

Summary: A pre-treatment and a 3-week post-treatment isolate of Neisseria gonorrhoeae from a 13-year-old boy treated with azithromycin in a single 1 g oral dose were characterized microbiologically. Both isolates were of the same serovar/ auxotype (1B6/non-requiring) and had similar antibiograms apart from erythromycin and azithromycin: the pre- and post-treatment MICs (minimum inhibitory concentrations) were: 1 mg/L and 32 mg/L to erythromycin and 0.125 mg/L and 3 mg/L to azithromycin. The finding that both isolates were 1B6/NR, had similar antibiograms (other than azithromycin and erythromycin), and no other 1B6/NR isolates were resistant to erythromycin supports the view that macrolide resistance developed following treatment. A high overall level of azithromycin susceptibility was confirmed by testing 67 clinical isolates: MIC 0.5 mg/L (range 0.023-0.75 mg/ L). We conclude that the long half-life of azithromycin which is beneficial in treating chlamydial infection may result in increased selective pressure for resistance in gonococci. This report also highlights the importance of antibiotic susceptibility surveillance of gonococci and stresses the need for appropriate treatment of gonococcal infection, particularly when it is prescribed outwith departments of genitourinary medicine. 90

Key Words: NEISSERIA GONORRHOEAE • ANTIBIOTICS • RESISTANCE • AZITHROMYCIN • ERYTHROMYCIN

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C J Bignell BASHH guideline for gonorrhoea Sex Transm Inf, October 1, 2004; 80(5): 330 - 331. [Full Text] [PDF]

				C A Ison, J W Mouton, K Jones, on behalf of the North Thames Audit Group, K A Fenton, and D M Livermore Which cephalosporin for gonorrhoea? Sex Transm Inf, October 1, 2004; 80(5): 386 - 388. [Abstract] [Full Text] [PDF]

				Fluoroquinolone Resistance in Neisseria gonorrhoeae, Hawaii, 1999, and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999 JAMA, October 18, 2000; 284(15): 1917 - 1919. [Full Text] [PDF]